Core Points - Exelixis is hosting its 2025 R&D Day focused on building next-generation oncology franchises [1] - The event features guest speakers who will discuss specific disease focus areas [1] - The company will make forward-looking statements regarding future developments and performance [2] Company Developments - Exelixis is emphasizing potential advancements in discovery, product development, and regulatory matters [2] - The company is exploring market and growth opportunities in the oncology sector [2] Risks and Uncertainties - Actual results may differ materially from the company's forward-looking statements due to various risks [2] - Key risk factors include product commercial success, market competition, and regulatory approval processes [2]